Home> Products> potential sensitivity

{ "products": [ { "_id": "689dc838bf323e16334fe2f6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CHONDROFLEX TRIO", "description": "CHONDROFLEX TRIO is a premium joint support supplement formulated to enhance joint health, flexibility, and mobility. It combines the synergistic effects of three powerful natural extracts: Rosehip Extract, Devil's Claw Extract, and Boswellia Serrata Extract. These ingredients are traditionally known for their anti-inflammatory, analgesic, and antioxidant properties, which collectively help to reduce joint pain, swelling, stiffness, and improve overall musculoskeletal wellness. This formulation is designed to aid those experiencing joint discomfort due to arthritis, osteoarthritis, or other degenerative joint conditions, supporting healthy joint function and promoting greater ease of movement.\n\n \n\nWhat is CHONDROFLEX TRIO?\n\nCHONDROFLEX TRIO is a tablet that contains a unique blend of natural extracts — Rosehip Extract, Devil's Claw Extract, and Boswellia Serrata Extract — formulated to target joint inflammation and pain. These extracts work together to protect cartilage, reduce joint inflammation, and support the repair of joint tissues. The supplement aims to improve joint flexibility and enhance overall joint health, making it suitable for individuals dealing with arthritis or age-related joint issues.\n\n \n\nUses of CHONDROFLEX TRIO\n \n\nSupports joint health and flexibility\n\nHelps reduce joint inflammation and swelling\n\nAlleviates joint pain and stiffness\n\nPromotes cartilage repair and regeneration\n\nImproves blood supply to the joints, enhancing nutrient delivery\n\nSupports overall musculoskeletal comfort and mobility\n\nMay aid in managing symptoms related to osteoarthritis and rheumatoid arthritis\n\nHelps maintain fluid balance within joints for better movement\n\n \n\nSide Effects of CHONDROFLEX TRIO\n\nWhile CHONDROFLEX TRIO is generally well tolerated, some individuals may experience the following side effects:\n\nMild gastrointestinal discomfort such as nausea, diarrhea, or constipation\n\nAllergic reactions including skin rashes, itching, or swelling (rare)\n\nPossible sensitivity reactions in some individuals, requiring discontinuation\nIt is important to consult with a healthcare provider if any side effects persist or worsen.\n\n \n\nPrecautions Before Using CHONDROFLEX TRIO\n \n\nConsult a healthcare professional before starting if you are pregnant or breastfeeding\n\nInform your doctor if you have any pre-existing medical conditions, especially liver or kidney disorders\n\nUse caution if you have a history of allergies to herbal supplements\n\nDo not exceed the recommended dosage without medical advice\n\nKeep out of reach of children\n\nStore in a cool, dry place away from direct sunlight\n\n \n\nDrug Interactions — What Drugs Interact with CHONDROFLEX TRIO?\n\nCHONDROFLEX TRIO may interact with certain medications, so it is essential to inform your healthcare provider about all medications you are taking before starting this supplement. Potential interactions include:\n\nBlood thinners (anticoagulants), as some ingredients may affect blood clotting\n\nAnti-inflammatory drugs or pain relievers, which may enhance or alter effect\n\nImmunosuppressant drugs, due to potential immune system modulation\n\nDiabetes medications, as some herbal components might influence blood sugar levels\n\nAlways seek professional guidance to avoid adverse effects related to drug interactions.\n\n \n\nConclusion\n\nCHONDROFLEX TRIO, with its potent blend of Rosehip Extract, Devil's Claw Extract, and Boswellia Serrata Extract, offers a natural and effective approach to managing joint health. By reducing inflammation, promoting cartilage repair, and enhancing joint flexibility, it provides relief from discomfort associated with various joint conditions. Regular use combined with medical supervision can contribute to improved joint function and overall quality of life. This supplement is a valuable choice for those seeking a natural alternative to support their joint wellness and mobility.", "price": 560.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2160, "imageuri": "https://productimages.withfloats.com/actual/689dc83c6a07538a7ce8bd8c.png", "tileimageuri": "https://productimages.withfloats.com/tile/689dc83c6a07538a7ce8bd8c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-14T11:27:52.965Z", "updatedon": "2025-08-14T11:27:52.965Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/chondroflex-trio/2160", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rosehip Extract, Devil's Claw Extract & Boswellia Serrata Extract Tablets", "category": "ORTHOPEDICS RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6890a38862235c25dfdb3b05", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLAVOSHIELD 1000", "description": "FLAVOSHIELD 1000 is a specialized health supplement formulated with a potent micronized purified flavonoid fraction derived from the Rutaceae family, containing 1000 mg per tablet. This high dosage ensures enhanced bioavailability and efficacy. Flavonoids are natural plant compounds known for their antioxidant, anti-inflammatory, and vascular protective properties. FLAVOSHIELD 1000 is designed to support and improve venous and lymphatic circulation, providing significant relief and therapeutic benefits to individuals suffering from circulatory disorders. Its micronized form allows for better absorption and faster action within the body.\n\nWhat is FLAVOSHIELD 1000?\nFLAVOSHIELD 1000 is a medicinal tablet that contains a micronized purified flavonoid fraction of Rutaceae at a strength of 1000 mg. The active flavonoid compounds help strengthen blood vessel walls, reduce capillary permeability, and improve overall microcirculation. These effects make it particularly useful in managing symptoms related to venous insufficiency and lymphatic circulation disorders.\n\nUses of FLAVOSHIELD 1000:\n\nTo improve venous tone and reduce venous stasis.\n\nTo alleviate symptoms associated with chronic venous insufficiency (CVI), such as leg heaviness, swelling, and pain.\n\nTo support healing and reduce inflammation in cases of hemorrhoids.\n\nTo enhance lymphatic drainage and reduce edema (swelling) caused by impaired circulation.\n\nTo protect blood vessels by reducing capillary fragility and permeability.\n\nTo improve overall vascular health and circulation efficiency.\n\nFLAVOSHIELD 1000 is used to treat conditions related to venous and lymphatic circulation, particularly chronic venous insufficiency (CVI) and hemorrhoids.\n\nSide Effects of FLAVOSHIELD 1000:\n\nMild gastrointestinal discomfort such as nausea or stomach upset.\n\nAllergic reactions including skin rash or itching in sensitive individuals.\n\nPossible headaches or dizziness in rare cases.\n\nVery rarely, hypersensitivity reactions may occur.\n\nConsult a healthcare professional if severe allergic symptoms or unusual reactions appear.\n\nPrecautions before Using FLAVOSHIELD 1000:\n\nInform your doctor if you have a history of allergies, especially to flavonoids or plant-based supplements.\n\nUse with caution if you are pregnant or breastfeeding; always seek medical advice before use.\n\nPeople with bleeding disorders or on anticoagulant therapy should use caution as flavonoids may affect blood clotting.\n\nAvoid using without medical supervision if you have any chronic disease or are taking other medications.\n\nDo not exceed the recommended dosage to prevent adverse effects.\n\nDrug Interactions: What Drugs Interact with FLAVOSHIELD 1000?\n\nFLAVOSHIELD 1000 may interact with blood thinners (anticoagulants) like warfarin by enhancing their effect, potentially increasing the risk of bleeding.\n\nIt may potentiate the effect of nonsteroidal anti-inflammatory drugs (NSAIDs).\n\nInteractions with immunosuppressants or other herbal supplements have not been well studied; caution is advised.\n\nAlways inform your healthcare provider about all medications and supplements you are taking to avoid adverse interactions.\n\nConclusion\nFLAVOSHIELD 1000, containing a micronized purified flavonoid fraction of Rutaceae, is a powerful supplement targeted at improving venous and lymphatic circulation. It offers effective relief for chronic venous insufficiency and hemorrhoids by strengthening blood vessels and reducing inflammation and swelling. While generally well tolerated, users should be mindful of possible side effects and drug interactions. Proper medical consultation is recommended before starting this supplement to ensure safe and effective use.", "price": 570.0, "discountamount": 171.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2153, "imageuri": "https://productimages.withfloats.com/actual/6890a38e9f44dc84d237abce.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890a38e9f44dc84d237abce.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:11:52.673Z", "updatedon": "2025-08-04T12:11:52.673Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/flavoshield-1000/2153", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Micronized purified flavonoid fraction of rutaceae 1000 mg tablets", "category": "GENERAL RANGE", "tags": [ "Micronized purified flavonoid fraction of rutaceae 1000 mg tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6825c6cc966e2a18bb4b35a6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA PIO", "description": "GLIDAPA PIO is a combination oral medication specially formulated to help manage type 2 diabetes mellitus. It combines two powerful antidiabetic agents, dapagliflozin and pioglitazone, to effectively control blood sugar levels. This medication is prescribed to patients when diet and exercise alone do not provide adequate glycemic control. By addressing blood glucose regulation through different mechanisms, GLIDAPA PIO helps reduce the risk of diabetes-related complications and supports overall metabolic health.\n\nKey Ingredients\nDapagliflozin (10mg): A sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by increasing the excretion of glucose through urine.\n\nPioglitazone (15mg): A thiazolidinedione that improves insulin sensitivity by acting on fat, muscle, and liver cells, facilitating better glucose uptake and utilization.\n\nKey Benefits\nHelps maintain stable blood glucose levels in adults with type 2 diabetes.\n\nCombines two complementary mechanisms to enhance blood sugar control.\n\nSupports weight management due to dapagliflozin’s glucose excretion effect.\n\nMay improve insulin sensitivity and reduce insulin resistance.\n\nReduces the risk of diabetes-related complications such as cardiovascular problems when combined with lifestyle changes.\n\nConvenient once-daily tablet formulation.\n\nHow Does It Work?\nDapagliflozin blocks SGLT2 proteins in the kidneys, preventing glucose reabsorption and promoting its elimination through urine, which lowers blood glucose. Pioglitazone acts on insulin-responsive tissues, enhancing the body’s sensitivity to insulin. This dual action helps reduce both insulin resistance and excess blood glucose, providing better overall glycemic control. By targeting different pathways, GLIDAPA PIO offers a synergistic effect to manage type 2 diabetes more effectively.\n\nDirections for Use\nTake GLIDAPA PIO exactly as prescribed by your healthcare provider.\n\nUsually taken once daily, with or without food, at the same time each day.\n\nDo not skip doses or stop the medication without consulting your doctor.\n\nMaintain a balanced diet and regular exercise as advised alongside the medication.\n\nInform your doctor about any other medications you are taking to avoid potential interactions.\n\nSide Effects\nSome patients may experience side effects while taking GLIDAPA PIO, including:\n\nUrinary tract infections or increased urination due to dapagliflozin.\n\nWeight gain or swelling caused by pioglitazone.\n\nRisk of low blood sugar (hypoglycemia) when combined with other antidiabetic drugs.\n\nPossible dizziness or fatigue.\n\nRarely, heart failure or bladder cancer risk (associated with pioglitazone).\n\nIf you notice symptoms like excessive thirst, sudden weight gain, swelling, shortness of breath, or any allergic reactions, seek medical advice immediately.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medication inform", "pioglitazone risk", "regular exercise", "balanced diet", "doctor maintain", "glucose uptake", "notice symptoms", "antidiabetic drugs", "swelling caused", "advised alongside", "skip doses", "healthcare provider", "effectively directions", "synergistic effect", "glycemic control", "cardiovascular problems", "complementary mechanisms", "fat muscle", "diabetesrelated complications", "insulin resistance", "bodys sensitivity", "glidapa pio", "urine pioglitazone 15mg", "taking glidapa pio", "bladder cancer risk", "improve insulin sensitivity", "improves insulin sensitivity", "glidapa pioglidapa pio", "dapagliflozin weight gain", "increased urination due", "urinary tract infections", "experience side effects", "insulinresponsive tissues enhancing", "liver cells facilitating" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2114, "imageuri": "https://productimages.withfloats.com/actual/6825c6ce65488af627fb2e46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6825c6ce65488af627fb2e46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-15T10:49:48.361Z", "updatedon": "2025-05-15T10:50:30.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-pio/2114", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dapagliflozin 10mg and pioglitazone 15mg tablets", "category": "DIABETIC RANGE", "tags": [ "Dapagliflozin, pioglitazone combination", "Dapagliflozin, pioglitazone combination", "Dapagliflozin Pioglitazone CDSCO" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6819f2b5b631af66ff847b24", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ORAVERSE M", "description": "ORAVERSE M is a meticulously formulated health supplement combining Myo-inositol (600 mg) with Metformin Hydrochloride (500 mg), specifically developed to boost metabolic wellness, particularly for those affected by polycystic ovary syndrome (PCOS) and insulin resistance. This dual-component preparation addresses hormonal equilibrium, glucose utilization, and ovarian health, providing a thorough solution for enhancing reproductive and metabolic functioning. Healthcare professionals frequently recommend it as part of treatment strategies for women with PCOS or individuals struggling with insulin sensitivity and irregular ovulation patterns.\nEssential Components:\n\nMyo-inositol IP (600 mg): A nutrient resembling vitamins (within the B-complex family), Myo-inositol serves a crucial function in cellular communication, particularly insulin signal transmission. It's recognized for its positive influence on ovarian activity, hormone regulation, and metabolic function.\nMetformin Hydrochloride (500 mg): A proven anti-diabetic medicine that helps reduce blood sugar and enhance insulin effectiveness. It's widely prescribed for Type 2 diabetes mellitus and PCOS-related insulin resistance.\n\nPrimary Advantages:\n\nBoosts Insulin Response: Both Myo-inositol and Metformin function complementarily to improve insulin sensitivity and reduce resistance, a key factor in metabolic disorders and PCOS.\nRegulates Menstrual Cycles & Ovulation: Particularly valuable for PCOS patients, ORAVERSE M may help normalize menstrual patterns and encourage ovulation.\nSupports Ovarian Health: Myo-inositol aids follicular development and egg quality, potentially enhancing fertility prospects.\nAlleviates High Androgen Symptoms: Helps manage manifestations like acne, excessive body hair, and hair thinning caused by elevated male hormone levels in PCOS.\nSupports Weight Management: Enhances metabolic factors that contribute to better weight control, especially for those with insulin resistance.\nReduces Diabetes Risk: By improving blood sugar regulation and lowering insulin levels, this formulation may help prevent progression to diabetes.\n\nFunctional Mechanism:\nORAVERSE M operates through a complementary action:\n\nMyo-inositol enhances insulin signaling at the cellular level, supporting glucose uptake and metabolism. It also influences luteinizing hormone (LH) and follicle-stimulating hormone (FSH) regulation, helping restore hormonal balance critical in PCOS.\nMetformin Hydrochloride decreases liver glucose production and increases insulin sensitivity in muscle and fat tissues, resulting in improved blood sugar control. For women with PCOS, Metformin also helps normalize menstrual cycles and ovulation.\n\nTogether, these ingredients help restore metabolic and reproductive wellness by addressing the root causes of PCOS and related metabolic disruptions.\nUsage Guidelines:\n\nStandard Dosage: One ORAVERSE M tablet is typically taken once or twice daily, as recommended by a physician.\nAdministration Method: Take with meals to minimize digestive discomfort. Swallow whole with water—avoid crushing or chewing.\nImportant: Always follow your healthcare provider's specific instructions regarding dosage and treatment duration.\n\nPotential Side Effects:\nORAVERSE M is generally well-tolerated, though some users may experience effects, particularly when beginning treatment:\n\nCommon Reactions:\n\nNausea\nBloating or gas\nMild diarrhea\nStomach discomfort\nMetallic taste (Metformin-related)\n\n\nLess Common but Significant:\n\nVitamin B12 deficiency (with prolonged Metformin use)\nMild dizziness or headache\nLow blood sugar (uncommon, especially when combined with other diabetes medications)", "price": 275.0, "discountamount": 83.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "diabetes medications", "mild dizziness", "experience effects", "generally welltolerated", "chewing important", "wateravoid crushing", "prevent progression", "weight control", "key factor", "reduce resistance", "widely prescribed", "positive influence", "cellular communication", "individuals struggling", "treatment strategies", "enhancing reproductive", "oraverse moraverse", "pcos metformin", "prolonged metformin", "restore metabolic", "metabolic disorders", "reproductive wellness", "crucial function", "insulin resistance", "insulin sensitivity", "pcos patients oraverse", "metformin function complementarily", "boost metabolic wellness", "increases insulin sensitivity", "improve insulin sensitivity", "lowering insulin levels", "enhance insulin effectiveness", "insulin signal transmission", "physician administration method", "fat tissues resulting", "hair thinning caused", "normalize menstrual patterns", "proven antidiabetic medicine", "nutrient resembling vitamins", "ovarian health providing" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2102, "imageuri": "https://productimages.withfloats.com/actual/6819f2b79d6e117a7e9250d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/6819f2b79d6e117a7e9250d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-06T11:29:57.58Z", "updatedon": "2025-05-06T11:29:57.58Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/oraverse-m/2102", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Myo-inositol IP (600 mg), Metformin Hydrochloride (500 mg)", "category": "Gynaecology", "tags": [ "myo-inositol 600 mg & metformin hydrochloride 500 mg (sustained release) tablets", "Myo-Inositol 600 mg and Metformin hydrochloride 500 mg Uses in Hindi", "myo-inositol 600 mg & metformin hydrochloride 500 mg uses", "myo-inositol 600 mg & metformin hydrochloride 500 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661adf866170d1ff8cb45d2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PM 500 ", "description": "TENELIGOLD PM 500 \nTeneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500mg\nTENELIGOLD PM 500 is a combination medication containing Teneligliptin, Pioglitazone, and Extended-Release Metformin Hydrochloride. It is primarily prescribed for the management of type 2 diabetes mellitus, a metabolic disorder characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nTeneligliptin (20mg): Teneligliptin belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. It works by inhibiting the DPP-4 enzyme, which enhances the levels of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones stimulate insulin secretion and inhibit glucagon release, leading to improved glucose control after meals.\n\nPioglitazone (15mg): Pioglitazone is a thiazolidinedione medication that improves insulin sensitivity in muscle and adipose (fat) tissues. It reduces glucose production in the liver and enhances glucose uptake in peripheral tissues. This action helps lower blood sugar levels and improves overall glycemic control.\n\nExtended-Release Metformin Hydrochloride (500mg): Metformin is a biguanide medication that reduces glucose production in the liver, decreases intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues. Extended-release formulations provide a sustained release of the drug, allowing for once-daily dosing and potentially reducing gastrointestinal side effects.\n\nKey Benefits of TENELIGOLD PM 500:\nComprehensive Glycemic Control: The combination of Teneligliptin, Pioglitazone, and Extended-Release Metformin offers comprehensive control over fasting and postprandial (after-meal) blood sugar levels.\n\nImproved Insulin Sensitivity: Pioglitazone and Metformin work synergistically to improve insulin sensitivity in cells, leading to better utilization of glucose and reduced insulin resistance.\n\nIncretin Hormone Enhancement: Teneligliptin enhances the action of incretin hormones, which regulate insulin secretion and glucagon levels, resulting in improved glucose regulation after meals.\n\nReduced Side Effects: Extended-release formulations of Metformin may reduce gastrointestinal side effects compared to immediate-release formulations.\n\nDosage and Administration:\nThe typical dosage of TENELIGOLD PM 500 is one tablet taken orally once daily, preferably with meals.\nSwallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nFollow your doctor's instructions regarding dosage adjustments based on your medical condition and response to treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-pm-500-134300", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "meals", "500mg", "EMAIL", "cells", "drugs", "GLP-1", "liver", "glass", "water", "dosing", "muscle", "action", "doctor", "fasting", "response", "treatment", "management", "one tablet", "utilization", "information", "postprandial", "Pioglitazone", "Key Benefits", "fat) tissues", "sterisonline", "sterispharma", "instructions", "DPP-4 enzyme", "CALL/WHATSAPP", "TENELIGOLD PM", "Teneligliptin", "glucose uptake", "Administration", "typical dosage", "glucose control", "glucagon levels", "glucagon release", "incretin hormones", "insulin secretion", "sustained release", "medical condition", "dosage adjustments", "metabolic disorder", "glucose regulation", "peripheral tissues", "insulin resistance", "glucose production", "healthcare provider", "insulin sensitivity", "biguanide medication", "Reduced Side Effects", "comprehensive control", "combination medication", "DPP-4) inhibitor class", "dipeptidyl peptidase-4", "high blood sugar levels", "overall glycemic control", "type 2 diabetes mellitus", "meal) blood sugar levels", "Incretin Hormone Enhancement", "thiazolidinedione medication", "Extended-release formulations", "inadequate insulin production", "intestinal glucose absorption", "gastrointestinal side effects", "Comprehensive Glycemic Control", "immediate-release formulations", "Extended-Release Metformin Hydrochloride", "glucose-dependent insulinotropic peptide", "Extended Release Metformin Hydrochloride" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1481, "imageuri": "https://productimages.withfloats.com/actual/6661adfd637f8700d7ca4512.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661adfd637f8700d7ca4512.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:39:20.713Z", "updatedon": "2024-06-28T12:21:18.417Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pm-500-/1481", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PM 500 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD PM 500", "Teneligliptin 20mg", "Pioglitazone 15mg", "Metformin Hydrochloride 500mg", "Teneligliptin Tablets 20 mg uses", "Teneligliptin 20 mg + Metformin 500", "Teneligliptin 20 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66602a0a161afa2274ff36b9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PROPENOL PLUS", "description": "PROPENOL PLUS\nPropranolol, Flunarizine\nComposition: Propenol Plus combines Propranolol and Flunarizine, offering a potent solution for migraine management.\n\nPropranolol: A beta-blocker, Propranolol reduces the frequency and severity of migraines by regulating blood flow and calming nerve impulses.\n\nFlunarizine: An antihistamine and calcium channel blocker, Flunarizine further aids in migraine prevention by stabilizing blood vessels and reducing their reactivity.\n\nIndications: Propenol Plus is prescribed for migraine prophylaxis, alleviating symptoms like severe headaches, visual disturbances, and sensitivity to light and sound.\n\nDosage: The recommended dose varies based on individual response and severity of symptoms. Always follow your healthcare provider's instructions.\n\nSide Effects: Possible side effects may include fatigue, dizziness, nausea, and changes in heart rate. Consult your doctor if these symptoms persist.\n\nPrecautions: Inform your doctor about any existing medical conditions or medications to avoid potential interactions. Avoid alcohol consumption while using Propenol Plus.\n\nPrice: Propenol Plus is available at affordable prices, making it accessible for migraine sufferers seeking effective relief.\n\nConclusion: Propenol Plus is a trusted choice for migraine management, combining the benefits of Propranolol and Flunarizine to provide lasting relief and improve quality of life.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/propenol-plus-134108\n\n\n\n\n\n\n", "price": 175.0, "discountamount": 122.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "life", "dose", "Email", "sound", "light", "doctor", "nausea", "Dosage", "product", "quality", "changes", "fatigue", "WhatsApp", "benefits", "symptoms", "severity", "dizziness", "migraines", "frequency", "Conclusion", "blood flow", "heart rate", "reactivity", "Precautions", "information", "sensitivity", "medications", "Indications", "Composition", "Flunarizine", "Propranolol", "beta-blocker", "sterispharma", "sterisonline", "instructions", "antihistamine", "PROPENOL PLUS", "blood vessels", "lasting relief", "trusted choice", "nerve impulses", "potent solution", "severe headaches", "effective relief", "affordable prices", "migraine sufferers", "migraine management", "individual response", "visual disturbances", "alcohol consumption", "healthcare provider", "migraine prevention", "migraine prophylaxis", "Possible side effects", "potential interactions", "calcium channel blocker", "existing medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1354, "imageuri": "https://productimages.withfloats.com/actual/66602a0d7b1fc3f9dd4a4e8c.png", "tileimageuri": "https://productimages.withfloats.com/tile/66602a0d7b1fc3f9dd4a4e8c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T09:04:10.391Z", "updatedon": "2024-06-29T12:44:37.263Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/propenol-plus/1354", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PROPENOL PLUS", "category": "CARDIOLOGYRANGE", "tags": [ "PROPENOL PLUS", "Propranolol, Flunarizine", "Flunarizine", "Propranolol 10 mg", "Propranolol side effects", "Propranolol uses", "Propranolol for anxiety", "Propranolol dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0baed91d281c30c72ddb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 5/ 1000 ", "description": "GLIDAPAFLOZIN M 5/ 1000 \nDapagliflozin (5mg), Metformin (1000mg)\nIntroduction\nGLIDAPAFLOZIN M 5/1000 is a combination medication designed to provide balanced and effective control over Type 2 diabetes. It combines Dapagliflozin (5 mg) and Metformin (1000 mg), offering a synergistic approach to managing blood glucose levels and supporting overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (5 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (1000 mg): Metformin is a widely used medication for Type 2 diabetes, improving insulin sensitivity, reducing liver glucose production, and decreasing intestinal glucose absorption. It helps lower blood sugar levels and may also support weight management.\nBenefits\nGLIDAPAFLOZIN M 5/1000 offers several advantages for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin, it provides a balanced approach to blood glucose control and metabolic parameters. This combination can lead to improved glycemic control, weight management, and cardiovascular health.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal to minimize gastrointestinal side effects. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 5/1000 should be taken in the morning to maximize its effectiveness throughout the day. It is important to follow the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 5/1000 may include urinary tract infections, genital infections, gastrointestinal disturbances (such as nausea or diarrhea), and potential vitamin B12 deficiency with long-term use. Patients should be aware of these potential side effects and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 5/1000 offers a balanced and effective treatment option for individuals with Type 2 diabetes, combining the benefits of Dapagliflozin and Metformin in a single tablet. Its dual-action mechanism targets multiple aspects of diabetes management, supporting improved glycemic control and metabolic health. Patients should consult their healthcare provider for personalized advice on dosage, monitoring, and management of potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-5-1000-133426", "price": 140.0, "discountamount": 42.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "meal", "Order", "EMAIL", "nausea", "kidneys", "1000 mg", "morning", "diarrhea", "improved", "concerns", "Patients", "increased", "Metformin", "one tablet", "Conclusion", "monitoring", "weight loss", "information", "individuals", "Introduction", "sterisonline", "tolerability", "sterispharma", "effectiveness", "long-term use", "single tablet", "Dapagliflozin", "CALL/WHATSAPP", "Type 2 diabetes", "dosing schedule", "SGLT2 inhibitor", "GLIDAPAFLOZIN M", "glycemic control", "multiple aspects", "balanced approach", "weight management", "effective control", "blood sugar levels", "several advantages", "Dosage adjustments", "genital infections", "diabetes management", "Common side effects", "personalized advice", "healthcare provider", "individual response", "insulin sensitivity", "synergistic approach", "glucose reabsorption", "metabolic parameters", "blood glucose control", "dual-action mechanism", "cardiovascular health", "Administration Dosage", "combination medication", "potential side effects", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "liver glucose production", "urinary glucose excretion", "effective treatment option", "lower blood glucose levels", "gastrointestinal side effects", "intestinal glucose absorption", "gastrointestinal disturbances", "potential vitamin B12 deficiency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1318, "imageuri": "https://productimages.withfloats.com/actual/665f0bb10c19ea48b943ceaf.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0bb10c19ea48b943ceaf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:42:22.464Z", "updatedon": "2024-06-04T12:42:22.464Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glidapaflozin-m-5-1000-/1318", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 5/ 1000 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0a9787f0960e14a296d5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 10/1000 ", "description": "GLIDAPAFLOZIN M 10/1000 \nDapagliflozin (10mg), Metformin (1000mg)\nIntroduction\nGLIDAPAFLOZIN M 10/1000 is a potent combination medication designed to effectively manage Type 2 diabetes. It combines Dapagliflozin (10 mg) and Metformin (1000 mg), providing a dual-action approach to blood glucose control and overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (1000 mg): Metformin is a cornerstone medication for Type 2 diabetes, improving insulin sensitivity, reducing liver glucose production, and decreasing intestinal glucose absorption. It helps lower blood sugar levels and may also support weight management.\nBenefits\nGLIDAPAFLOZIN M 10/1000 offers several advantages for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin at higher doses, it provides comprehensive control over blood glucose levels and metabolic parameters. This combination can lead to improved glycemic control, weight management, and cardiovascular health.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal to minimize gastrointestinal side effects. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 10/1000 should be taken in the morning to maximize its effectiveness throughout the day. It is important to adhere to the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 10/1000 may include urinary tract infections, genital infections, gastrointestinal disturbances (such as nausea or diarrhea), and potential vitamin B12 deficiency with long-term use. Patients should be aware of these potential side effects and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 10/1000 provides a comprehensive and effective treatment option for individuals with Type 2 diabetes, combining the benefits of Dapagliflozin and Metformin in a single tablet. Its dual-action mechanism targets multiple aspects of diabetes management, supporting improved glycemic control and metabolic health. Patients should consult their healthcare provider for personalized advice on dosage, monitoring, and management of potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-10-1000-133425", "price": 205.0, "discountamount": 61.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "meal", "lower", "EMAIL", "Order", "nausea", "kidneys", "morning", "1000 mg", "diarrhea", "concerns", "improved", "Patients", "Metformin", "Conclusion", "monitoring", "one tablet", "weight loss", "information", "individuals", "higher doses", "Introduction", "sterisonline", "tolerability", "sterispharma", "effectiveness", "Dapagliflozin", "CALL/WHATSAPP", "long-term use", "single tablet", "SGLT2 inhibitor", "GLIDAPAFLOZIN M", "dosing schedule", "Type 2 diabetes", "multiple aspects", "glycemic control", "weight management", "genital infections", "blood sugar levels", "Dosage adjustments", "several advantages", "Common side effects", "healthcare provider", "insulin sensitivity", "personalized advice", "individual response", "diabetes management", "glucose reabsorption", "dual-action approach", "metabolic parameters", "blood glucose levels", "dual-action mechanism", "cardiovascular health", "comprehensive control", "Administration Dosage", "blood glucose control", "cornerstone medication", "potential side effects", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "liver glucose production", "urinary glucose excretion", "effective treatment option", "gastrointestinal side effects", "potent combination medication", "gastrointestinal disturbances", "intestinal glucose absorption", "potential vitamin B12 deficiency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1317, "imageuri": "https://productimages.withfloats.com/actual/665f0a99c06ee12d88cb43d9.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0a99c06ee12d88cb43d9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:37:43.401Z", "updatedon": "2024-06-04T12:37:43.401Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-m-10-1000-/1317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 10/1000 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }